Neuberger Berman Group
ONC

Neuberger Berman Group’s BeOne Medicines Ltd ONC Stock Holding History

Neuberger Berman Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Buy
6,502
+2,098
+48% +$618K ﹤0.01% 1320
2026
Q1 		$1.29M Buy
4,404
+154
+4% +$49.8K ﹤0.01% 1322
2025
Q4 		$1.29M Buy
4,250
+353
+9% +$116K ﹤0.01% 1323
2025
Q3 		$1.31M Buy
3,897
+241
+7% +$73.2K ﹤0.01% 1283
2025
Q2 		$884K Buy
+3,656
New +$897K ﹤0.01% 1394

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Neuberger Berman Group's ONC Position: Q2 2026 in Review

Neuberger Berman Group increased its BeOne Medicines Ltd (ONC) stake by 48% in Q2 2026, buying an estimated $618K and bringing the position to 6,502 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1320.

Neuberger Berman Group first reported a position in ONC in Q2 2025 and has held it in 5 quarters since. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Neuberger Berman Group held 6,502 shares of BeOne Medicines Ltd worth $1.87M as of Q2 2026.
  • Neuberger Berman Group bought 2,098 BeOne Medicines Ltd shares in Q2 2026, an estimated $618K.
  • BeOne Medicines Ltd made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #1320 holding.
  • Neuberger Berman Group first reported a position in BeOne Medicines Ltd in Q2 2025 and has held it in 5 quarters since.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.